Open AccessHow has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study
Author(s) -
Yiyoung Kwon,
Eun Sil Kim,
Yon Ho Choe,
Mi Jin Kim
Publication year - 2022
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v28.i28.3666
Subject(s) - medicine , ulcerative colitis , colonoscopy , infliximab , gastroenterology , group b , surgery , disease , colorectal cancer , cancer
In Korea, infliximab was approved for use in children with ulcerative colitis (UC) in October 2012.